PHARMACIE CAILLABET : revenue, balance sheet and financial ratios

PHARMACIE CAILLABET is a French company founded 6 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ANGLET (64600), this company of category PME shows in 2024 a revenue of 2.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE CAILLABET (SIREN 881642292)
Indicator 2025 2024 2023 2022 2021
Revenue N/C 2 391 457 € 2 390 074 € 2 468 527 € 1 672 531 €
Net income 34 473 € -18 689 € 102 008 € 196 279 € 486 €
EBITDA N/C 41 392 € 185 008 € 320 978 € 49 805 €
Net margin N/C -0.8% 4.3% 8.0% 0.0%

Revenue and income statement

In 2025, PHARMACIE CAILLABET generates positive net income of 34 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2025: 486 € -> 34 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

34 473 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 406%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 17%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

405.952%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

16.66%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

48.4%

Solvency indicators evolution
PHARMACIE CAILLABET

Sector positioning

Debt ratio
405.95 2025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average

In 2025, the debt ratio of PHARMACIE CAILLABET (405.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
16.66% 2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Watch

In 2025, the financial autonomy of PHARMACIE CAILLABET (16.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
45.51 years 2024
2023
2024
Q1: 0.52 years
Med: 3.18 years
Q3: 7.6 years
Watch

In 2024, the repayment capacity of PHARMACIE CAILLABET (45.51) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 128.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

128.981

Liquidity indicators evolution
PHARMACIE CAILLABET

Sector positioning

Liquidity ratio
128.98 2025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Watch -30 pts over 3 years

In 2025, the liquidity ratio of PHARMACIE CAILLABET (128.98) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
15.86x 2024
2023
2024
Q1: 0.0x
Med: 2.34x
Q3: 7.73x
Excellent +17 pts over 2 years

In 2024, the interest coverage of PHARMACIE CAILLABET (15.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 46 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1106 days. Excellent situation: suppliers finance 1060 days of the operating cycle (retail model).

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

46 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

1106 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE CAILLABET

Positioning of PHARMACIE CAILLABET in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE CAILLABET is estimated at 547 607 € (range 371 609€ - 859 271€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
371k€ 547k€ 859k€
547 607 € Range: 371 609€ - 859 271€
NAF 5 année 2025

Valuation method used

Net Income Multiple
34 473 € × 15.9x = 547 608 €
Range: 371 609€ - 859 272€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE CAILLABET with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE CAILLABET

What is the revenue of PHARMACIE CAILLABET ?

The revenue of PHARMACIE CAILLABET in 2024 is 2.4 M€.

Is PHARMACIE CAILLABET profitable?

Yes, PHARMACIE CAILLABET generated a net profit of 34 k€ in 2025.

Where is the headquarters of PHARMACIE CAILLABET ?

The headquarters of PHARMACIE CAILLABET is located in ANGLET (64600), in the department Pyrenees-Atlantiques.

Where to find the tax return of PHARMACIE CAILLABET ?

The tax return of PHARMACIE CAILLABET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE CAILLABET operate?

PHARMACIE CAILLABET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.